用于癌症免疫治疗的双特异性-纳米酶结合物的设计
Danhong Chen1, Ran Xu1, Xiaoyun Ye1
1School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
Cell reports. Medicine
|January 22, 2026
概括
这项研究引入了一种双特异性-纳米酶合物 (BsPNEC) 来克服瘤免疫抑制. 通过向髓状细胞和T细胞,BSPNEC增强了抗PD-1疗法,增强了对癌症的免疫反应.
科学领域:
- 生物医学工程 生物医学工程
- 癌症免疫学 癌症免疫学
- 纳米技术 纳米技术
背景情况:
- 癌症免疫疗法面临来自免疫抑制瘤微环境 (TME) 的挑战.
- 关键的免疫抑制因素包括PD-L1 (编程死亡配体1) 和CXCL8,它们会损害T细胞功能并招募髓质细胞.
- 由于这些与TME相关的障碍,现有的疗法往往因有效性有限而扎.
研究的目的:
- 设计一种新的双特异性-纳米酶结合物 (BsPNEC) 用于协同的癌症免疫疗法.
- 在TME中同时准PD-L1和CXCL8通路.
- 为了提高抗PD-1疗法在耐药瘤模型中的疗效.
主要方法:
- 开发一种针对CXCR1 / 2的抗蛋白分解D- (q6w),与阻断PD-L1的结合,形成qGA.
- qGA与Fe3O4纳米酶的结合,具有过氧化酶模拟活性.
- 利用纳米酶产生活性氧物种 (ROS) 并激活cGAS-STING通路用于T细胞强化.
主要成果:
- 在抗PD-1耐药模型中,BSPNEC证明有效抑制瘤生长.
- BsPNEC成功激活了cGAS-STING通路,导致CD8+ T细胞透和激活的增强.
- 该平台提供瘤向输送和磁共振成像 (MRI) 对比能力.
结论:
- BsPNEC代表了一种协同免疫治疗策略,该策略重塑了免疫抑制的TME.
- 这种方法通过放大T细胞介导的免疫反应来克服对PD-1阻塞的抵抗.
- 经过工程设计的BSPNEC平台通过结合向输送,成像和强大的免疫调节,显示了先进癌症治疗的前景.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Conjugated Proteins
27.5K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
27.5K
Conjugated Proteins
3.2K
3.2K
Peptide Bonds
82.5K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
82.5K
Conjugation
2.0K
Conjugation is a form of horizontal gene transfer that primarily occurs in bacteria and some archaea, promoting genetic diversity and adaptation. Bacteria can acquire resistance genes through conjugative plasmids, allowing them to survive antibiotic treatments that would otherwise be lethal. This process involves direct contact between cells through specialized structures such as the sex pilus and is mediated by conjugative plasmids, including the F (fertility) factor.Conjugation requires...
2.0K
Mechanism of Conjugation
908
Bacterial conjugation is a mechanism of horizontal gene transfer that enables the exchange of genetic material between bacterial cells through direct contact. This process is facilitated by a donor cell carrying a conjugative plasmid, which encodes genes necessary for pilus formation, DNA replication, and transfer. The conjugative plasmid plays a central role in initiating and executing the transfer of genetic material.The tra region of the conjugative plasmid encodes proteins responsible for...
908


